135 related articles for article (PubMed ID: 33481394)
1. Characteristics and Survival Outcomes of Second Primary Cancers in Long-term Retinoblastoma Survivors.
Zhao NO; Daewoo P; El-Hadad C; Debnam JM; Ning J; Esmaeli B
Asia Pac J Ophthalmol (Phila); 2021 Jan; 10(4):366-372. PubMed ID: 33481394
[TBL] [Abstract][Full Text] [Related]
2. Chronic medical conditions in adult survivors of retinoblastoma: Results of the Retinoblastoma Survivor Study.
Friedman DN; Chou JF; Oeffinger KC; Kleinerman RA; Ford JS; Sklar CA; Li Y; McCabe MS; Robison LL; Marr BP; Abramson DH; Dunkel IJ
Cancer; 2016 Mar; 122(5):773-81. PubMed ID: 26755259
[TBL] [Abstract][Full Text] [Related]
3. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE
J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271
[TBL] [Abstract][Full Text] [Related]
4. Second primary tumors in retinoblastoma survivors: a study of 7 Asian Indian patients.
Kaliki S; Palkonda VAR
Int Ophthalmol; 2020 Dec; 40(12):3303-3308. PubMed ID: 32737729
[TBL] [Abstract][Full Text] [Related]
5. Incidence of second cancers after radiotherapy and systemic chemotherapy in heritable retinoblastoma survivors: A report from the German reference center.
Temming P; Arendt M; Viehmann A; Eisele L; Le Guin CH; Schündeln MM; Biewald E; Astrahantseff K; Wieland R; Bornfeld N; Sauerwein W; Eggert A; Jöckel KH; Lohmann DR
Pediatr Blood Cancer; 2017 Jan; 64(1):71-80. PubMed ID: 27567086
[TBL] [Abstract][Full Text] [Related]
6. Variation of second cancer risk by family history of retinoblastoma among long-term survivors.
Kleinerman RA; Yu CL; Little MP; Li Y; Abramson D; Seddon J; Tucker MA
J Clin Oncol; 2012 Mar; 30(9):950-7. PubMed ID: 22355046
[TBL] [Abstract][Full Text] [Related]
7. Risk of subsequent malignant neoplasms in long-term hereditary retinoblastoma survivors after chemotherapy and radiotherapy.
Wong JR; Morton LM; Tucker MA; Abramson DH; Seddon JM; Sampson JN; Kleinerman RA
J Clin Oncol; 2014 Oct; 32(29):3284-90. PubMed ID: 25185089
[TBL] [Abstract][Full Text] [Related]
8. Whole-body magnetic resonance imaging as surveillance for subsequent malignancies in preadolescent, adolescent, and young adult survivors of germline retinoblastoma: An update.
Friedman DN; Hsu M; Moskowitz CS; Francis JH; Lis E; Fleischut MH; Oeffinger KC; Walsh M; Tonorezos ES; Sklar CA; Abramson DH; Dunkel IJ
Pediatr Blood Cancer; 2020 Jul; 67(7):e28389. PubMed ID: 32386119
[TBL] [Abstract][Full Text] [Related]
9. Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up.
Kleinerman RA; Tucker MA; Tarone RE; Abramson DH; Seddon JM; Stovall M; Li FP; Fraumeni JF
J Clin Oncol; 2005 Apr; 23(10):2272-9. PubMed ID: 15800318
[TBL] [Abstract][Full Text] [Related]
10. Subsequent malignant neoplasms in the pediatric age in retinoblastoma survivors in Argentina.
Villanueva G; Sampor C; Moreno F; Alderete D; Moresco A; Pinto N; Szijan I; Schaiquevich P; Felice MS; Rose A; Zubizarreta P; Sgroi M; Fandiño A; Chantada G
Pediatr Blood Cancer; 2022 Aug; 69(8):e29710. PubMed ID: 35451226
[TBL] [Abstract][Full Text] [Related]
11. Clinical presentation and treatment outcome of retinoblastoma in children of South Western China.
Gao J; Zeng J; Guo B; He W; Chen J; Lu F; Chen D
Medicine (Baltimore); 2016 Oct; 95(42):e5204. PubMed ID: 27759657
[TBL] [Abstract][Full Text] [Related]
12. Secondary cancers after a childhood cancer diagnosis: a nationwide hospital-based retrospective cohort study in Japan.
Ishida Y; Qiu D; Maeda M; Fujimoto J; Kigasawa H; Kobayashi R; Sato M; Okamura J; Yoshinaga S; Rikiishi T; Shichino H; Kiyotani C; Kudo K; Asami K; Hori H; Kawaguchi H; Inada H; Adachi S; Manabe A; Kuroda T
Int J Clin Oncol; 2016 Jun; 21(3):506-16. PubMed ID: 26620038
[TBL] [Abstract][Full Text] [Related]
13. Tobacco use in adult long-term survivors of retinoblastoma.
Foster MC; Kleinerman RA; Abramson DH; Seddon JM; Tarone RE; Tucker MA
Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1464-8. PubMed ID: 16896033
[TBL] [Abstract][Full Text] [Related]
14. Lifetime risks of common cancers among retinoblastoma survivors.
Fletcher O; Easton D; Anderson K; Gilham C; Jay M; Peto J
J Natl Cancer Inst; 2004 Mar; 96(5):357-63. PubMed ID: 14996857
[TBL] [Abstract][Full Text] [Related]
15. Mortality from second tumors among long-term survivors of retinoblastoma.
Eng C; Li FP; Abramson DH; Ellsworth RM; Wong FL; Goldman MB; Seddon J; Tarbell N; Boice JD
J Natl Cancer Inst; 1993 Jul; 85(14):1121-8. PubMed ID: 8320741
[TBL] [Abstract][Full Text] [Related]
16. Survival trends for patients with retinoblastoma between 2000 and 2018: What has changed?
Abdelazeem B; Abbas KS; Shehata J; El-Shahat NA; Eltaras MM; Qaddoumi I; Alfaar AS
Cancer Med; 2023 Mar; 12(5):6318-6324. PubMed ID: 36479934
[TBL] [Abstract][Full Text] [Related]
17. Psychosocial Outcomes in Adult Survivors of Retinoblastoma.
Ford JS; Chou JF; Sklar CA; Oeffinger KC; Novetsky Friedman D; McCabe M; Robison LL; Kleinerman RA; Li Y; Marr BP; Abramson DH; Dunkel IJ
J Clin Oncol; 2015 Nov; 33(31):3608-14. PubMed ID: 26417002
[TBL] [Abstract][Full Text] [Related]
18. RETINOBLASTOMA IN INDIA: Clinical Presentation and Outcome in 1,457 Patients (2,074 Eyes).
Kaliki S; Patel A; Iram S; Ramappa G; Mohamed A; Palkonda VAR
Retina; 2019 Feb; 39(2):379-391. PubMed ID: 29210937
[TBL] [Abstract][Full Text] [Related]
19. Long-term medical outcomes in survivors of extra-ocular retinoblastoma: the Memorial Sloan-Kettering Cancer Center (MSKCC) experience.
Friedman DN; Sklar CA; Oeffinger KC; Kernan NA; Khakoo Y; Marr BP; Wolden SL; Abramson DH; Dunkel IJ
Pediatr Blood Cancer; 2013 Apr; 60(4):694-9. PubMed ID: 22911631
[TBL] [Abstract][Full Text] [Related]
20. Mortality from second tumour among long-term survivors of retinoblastoma: a retrospective analysis of the Italian retinoblastoma registry.
Acquaviva A; Ciccolallo L; Rondelli R; Balistreri A; Ancarola R; Cozza R; Hadjistilianou D; Francesco SD; Toti P; Pastore G; Haupt R; Carli M; Santoro N; Di Cataldo A; Fiorillo A; Indolfi P; Nucci P; Sandri A; Porta F; Porcaro AB; Tamaro P; Morgese G
Oncogene; 2006 Aug; 25(38):5350-7. PubMed ID: 16936757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
